Description:

SOUTHWEST ONCOLOGY GROUP S0600 CONCOMITANT MEDICATION FORM Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=258561E9-CE1C-6F0C-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=258561E9-CE1C-6F0C-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 8/27/12
  2. 1/8/15
Uploaded on:

January 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00499369 Treatment - SOUTHWEST ONCOLOGY GROUP S0600 CONCOMITANT MEDICATION FORM - 2582968v1.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0600 CONCOMITANT MEDICATION FORM
    1. No Instruction available.
Header
Unnamed Module 2
Is patient on anti-hypertensive therapy
Unnamed Module 2
Is the patient on anticoagulant therapy
Anti-Coagulant Drugs
Unnamed Module 2
Is the patient on magnesium supplements
Route of Administration
Comments

Similar models